Roche, Eli Lilly win FDA approval for Alzheimer's blood test
LLY Lilly(Eli) & Co
$1306.69 +2.83%
View chart & analysis → 
- 1Roche (RHHBY) and Eli Lilly (LLY) have secured FDA approval for the Alzheimer's blood test Elecsys pTau217.
- 2The test targets patients aged 55 and older showing cognitive decline and can be performed on more than 4,500 Roche analyzers across the United States.
- 3It offers greater accessibility than existing PET and cerebrospinal fluid tests, with Labcorp (LH) and Quest Diagnostics (DGX) planning to provide the test.
Source InvestorsHub +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.